The clinivation Global^® xi enterprise solution for Market Clearance Management enables executives and their teams to address the challenges of execution, effective governance, and lean business performance in their global market clearance operations. By enabling excellence in global market clearance operations to advance the revenue intrinsic to market clearance success, clinivation Global^® xi liberates revenue that's trapped-in-process.

Headquartered in St. Paul, Minnesota, St. Jude Medical Cardiovascular Division offers technologies for treating patients with cardiovascular and peripheral vascular disease in three major areas: structural heart disease, carotid artery disease, and vascular access and closure. The division was a result of merging the Cardiac Surgery and Cardiology Divisions on January 1, 2007 in efforts to increase operating efficiencies and stimulate research and development. St. Jude Medical provides a growing portfolio of tissue valves, the industry's gold standard mechanical heart valve and valve repair products to cardiac surgeons. The company offers vascular closure products and a developing pipeline of technologies to physicians performing interventional procedures.
For more information, please visit www.sjm.com.

St. Jude Medical, Inc. is headquartered in St. Paul, Minnesota and employs approximately 12,000 people worldwide. They are dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. St. Jude Medical was named by Fortune Magazine's "Most Admired Medical and Precision Equipment Company" in 2007 and 2008.
For more information, please visit www.sjm.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 100,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.